Abstract
ObjectiveTo quantify the neuromuscular blockade (NMB) produced by atracurium in either sevoflurane or propofol-anaesthetized dogs. AnimalsTwelve healthy, female adult mixed-breed dogs weighing 13 ± 3 kg (range 10–22 kg). Materials and methodsThree doses of atracurium (0.1, 0.2 and 0.3 mg kg−1) were tested at 1-week intervals. Anaesthesia was induced with inhaled sevoflurane or intravenous propofol and maintained with end-tidal sevoflurane concentrations of 1.95% (1.25 × MAC) or propofol 0.6 mg kg−1 minute−1 respectively. Acceleromyography and train-of-four stimulation of the fibular nerve were used for the assessment of NMB. The percentage depression of the first twitch (T1) and the fourth to the first twitch ratio (T4/T1), the maximum degree of neuromuscular block achieved and surgical muscle relaxation were recorded. Before and during neuro muscular blockade (at 10 minute intervals) body temperature, ECG, arterial blood pressure, inspired and expired CO2 concentrations and SpO2 were recorded. ResultsAtracurium produced a dose-dependent duration of NMB in both propofol and sevoflurane-anaesthetized dogs. Duration of block was longer in dogs anaesthetized with sevoflurane. All studied doses of atracurium caused twitch depression ≥95% with little or no cardiovascular changes. ConclusionsSevoflurane produces a clinically relevant potentiation of atracurium-induced NMB in dogs compared with propofol. Clinical relevanceSignificant differences in the potentiation of NMB drugs are encountered with commonly used anaesthetics in the dog.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.